ClinicaliQ Trial Snapshot
- Wearable Devices for Patient Monitoring in Long QT Syndrome — Recruiting • Cardiology / Cardiovascular • NCT06887387.
- What is being tested: Utility of wearable devices for continuous patient monitoring in Long QT syndrome, a rare inherited cardiac arrhythmia disorder characterised by prolonged ventricular repolarisation and risk of sudden cardiac death.
- Patient eligibility overview: The study targets patients with confirmed Long QT syndrome diagnosis, likely including both symptomatic individuals and asymptomatic carriers, across various age groups and disease severity profiles.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The main research question of this study is whether wearable devices have utility in monitoring patients with Long QT syndrome.
Eligibility Snapshot
- : * Clinical diagnosis of Long QT Syndrome * Aged 18 years or over * Phone with iOS version 15 or Android OS 9.0 or higher * Able and willing to provide informed consent
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.